Application of a Chinese medicine composition in preparing drugs for reproductive diseases
Through the ethanol extraction and concentration preparation of traditional Chinese medicine compositions, the problem of the poor effect of the prior art in the treatment of male infertility, especially oligospermia, is solved, and a significant improvement in improving sperm motility and reproductive health is achieved.
Patent Information
- Application Number
- CN202411048193.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-08-01
AI Technical Summary
The prior art has not been effective in treating male infertility, especially oligospermia, and traditional Chinese medicine has not been fully developed in improving reproductive diseases.
Using a traditional Chinese medicine composition, including ginseng, deer antler, astragalus, turtle shell gum, rehmannia ginger, actis saphenous, yam, salvia miltiorrhiza, wolfberry, cudscuta, Schisandra chinensis and mulberry parasite, it is prepared into oral liquid by ethanol extraction and concentration, and is used to improve the Sperm motility and treatment of male infertility.
Through experiments, it was found that traditional Chinese medicine compositions can significantly improve sperm motility, have good therapeutic effects on oligospermia, improve sperm density and testosterone levels, and significantly improve male reproductive health.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention relates to the field of medical technology, and in particular to application of a traditional Chinese medicine composition in the preparation of reproductive disease medicines. Background Art
[0002] Infertility refers to the situation where a couple has a normal sex life after marriage and does not take any contraceptive measures, but there is no pregnancy after one year of cohabitation. With the increasing pressure of life, the increasingly serious environmental pollution and the problem of food safety, the incidence of infertility has an upward trend, of which the female factor alone is about 50%, the male factor alone is about 30%, and the total of men and women is about 20%. And the cause of most male infertility is not very clear. Among men with a clear cause of infertility, the main cause is oligospermia and asthenospermia. The drugs used in Western medicine to treat male infertility mainly include vitamins, trace elements, testosterone, human chorionic gonadotropin and clomiphene, etc. Most of them are based on empirical treatment, and the treatment effect is not ideal.
[0003] Traditional Chinese medicine has good clinical effects in treating male infertility. For example, CN102961493A provides a traditional Chinese medicine for treating male infertility of kidney essence deficiency type, which is composed of the following components, and the weight of each component is: 10-14 grams of Aralia thornii, 13-17 grams of Millettia reticulata, 6-10 grams of Morinda officinalis, 8-12 grams of Carapax tortoise shell, 10 grams of Codonopsis pilosula, 6-10 grams of Rehmanniae glutinosae, 13-17 grams of Cuscuta australis, 6-10 grams of Rhizoma Cibotii, 13-17 grams of Rhizoma Cibotii, 13-17 grams of Rhizoma Cibotii, 4-8 grams of Cortex Moutan, 13-17 grams of Salvia miltiorrhiza, 6-10 grams of Cortex Phellodendri, and 8-12 grams of Radix Astragali. The traditional Chinese medicine formula is targeted at the specific classification of male infertility, reuses traditional Chinese medicine that warms the kidney and replenishes essence, and is also used to benefit yin. It has good efficacy, strong pertinence, and no toxic side effects in treating male infertility of kidney essence deficiency type. CN107375700A provides a herbal compound preparation for preventing and treating male infertility. The herbal compound preparation is prepared by extracting and concentrating the roots of Tripterygium wilfordii, seeds of Anders' water sedge, seeds of Mucuna pruriens, seeds of Mimosa pudica, gum arabic, roots of Astragalus membranaceus, seed coats of Plantago asiatica, gum kapok and roots of Eurycoma longifolia with ethanol, methanol, acetone and water. Human trials have shown that the herbal compound preparation can effectively improve the health level of male infertility patients, increase semen volume, sperm density and sperm motility, and significantly increase male testosterone and hormone levels, and has the potential value of being developed into a drug or related food for treating male infertility.
[0004] Oligospermia and asthenospermia are classified as "cold sperm and few sperm" in the category of traditional Chinese medicine. Traditional Chinese medicine also believes that a decrease in the number of sperm indicates insufficient kidney essence; a low sperm survival rate or poor activity indicates kidney qi deficiency. Traditional Chinese medicine believes that the pathological changes of male infertility are mainly in the kidney. If the kidney qi is sufficient, the sperm will be abundant, and the production of sperm depends on the nourishment of kidney essence and the warmth of kidney yang. Guiqishen oral liquid is a Chinese patent medicine, mainly made of ginseng, deer antler, astragalus, tortoise shell glue, prepared rehmannia, Achyranthes bidentata, Chinese yam, salvia miltiorrhiza, wolfberry, dodder seed, Schisandra chinensis and mistletoe. It has the function of nourishing yin and tonifying yang, and is used for dysplasia, long-term illness, physical weakness, fatigue, insomnia and other symptoms. At present, no research has been found on the use of Guiqishen oral liquid in drugs related to improving or treating male reproductive diseases. Summary of the invention
[0005] The purpose of the present invention is to provide an application of a traditional Chinese medicine composition in the preparation of reproductive disease medicines.
[0006] In order to achieve the above object, the present invention adopts the following technical solutions:
[0007] In a first aspect, the present invention provides a use of a traditional Chinese medicine composition in preparing a medicine for reproductive diseases.
[0008] The reproductive disease described in the present invention is a disease that can cause male sperm deficiency and / or decreased male sperm motility.
[0009] The reproductive diseases include male infertility and male prostatitis.
[0010] In some embodiments, the application is the application of the traditional Chinese medicine composition in the preparation of a drug for improving sperm quality.
[0011] In some embodiments, the application is the application of the traditional Chinese medicine composition in the preparation of male infertility drugs.
[0012] Preferably, the male infertility is oligospermia and asthenospermia.
[0013] The medicine in the present invention is oral liquid, tablet, pill, dripping pill, capsule, granule, powder, granule, injection, mixture or suspension; preferably oral liquid, tablet, capsule, granule or powder; more preferably oral liquid.
[0014] The medicine of the present invention also includes a pharmaceutically acceptable carrier.
[0015] The traditional Chinese medicine composition of the present invention comprises ginseng, pilose antler, astragalus, tortoise shell glue, prepared rehmannia root, cyathula, yam, salvia miltiorrhiza, wolfberry, dodder seed, schisandra chinensis and mistletoe.
[0016] In some embodiments, the Chinese medicine composition includes, by weight, 30-60 parts of ginseng, 0.5-4 parts of deer antler, 15-35 parts of astragalus, 10-30 parts of tortoise shell glue, 15-35 parts of rehmannia root, 10-30 parts of Achyranthes bidentata, 15-40 parts of yam, 20-40 parts of salvia miltiorrhiza, 15-30 parts of wolfberry, 15-30 parts of dodder seed, 2-8 parts of schisandra chinensis and 10-30 parts of mistletoe.
[0017] Preferably, the Chinese medicine composition comprises, by weight, 50 parts of ginseng, 2 parts of pilose antler, 20 parts of astragalus, 20 parts of tortoise shell glue, 20 parts of rehmannia root, 20 parts of achyranthes bidentata, 20 parts of yam, 30 parts of salvia miltiorrhiza, 20 parts of wolfberry, 20 parts of dodder seed, 6 parts of schisandra chinensis and 20 parts of mistletoe.
[0018] In some embodiments, the preparation method of the Chinese medicine composition is:
[0019] For the above twelve herbs, extract ginseng with 50-85v / v% ethanol by heating and refluxing at least once, and combine the extracts; recover the ethanol, concentrate to 1-3 times of the original amount of the herb, add ethanol to an alcohol content of 70-85wt%, let it settle, take the supernatant, recover the ethanol, and concentrate to a relative density of 1.12-1.15 (50°C);
[0020] Add 30-60v / v% ethanol to deer antler, heat and reflux for extraction four times, combine the extracts, add water to the residue and boil it at least once, combine the water decoction and the ethanol extract, filter, recover ethanol from the filtrate, concentrate to a ratio of 1-2:1 with the original medicinal material, add ethanol to an alcohol content of 75-90wt%, place to precipitate, take the supernatant, recover ethanol, and concentrate to a relative density of 1.12-1.15 (50°C);
[0021] Add water to the tortoise shell glue and heat it to melt;
[0022] The remaining medicinal ingredients are decocted with water at least once, the decoctions are combined, filtered, and the filtrate is concentrated to 1-3 times the amount of the original medicinal materials, ethanol is added to the alcohol content to be 60-70wt%, and the precipitation is allowed to proceed. The supernatant is taken to recover the ethanol and concentrated to a relative density of 1.12-1.15 (50°C);
[0023] Take sucrose and dissolve it in water, heat and boil it to make a simple sugar syrup; dissolve sorbic acid in ethanol;
[0024] Combine the above-mentioned medicinal solutions, monosaccharide syrup and sorbic acid ethanol solution, add water to make up to volume, stir evenly, let stand, filter, fill and sterilize to obtain the product.
[0025] The beneficial effects of the present invention are:
[0026] It is found through experiments that the Chinese medicine composition of the present invention can improve sperm motility and has a good therapeutic effect on male infertility caused by oligospermia and asthenospermia. DETAILED DESCRIPTION
[0027] The following examples are only used to help understand the method of the present invention and its core concept. It should be noted that, for those skilled in the art, without departing from the principles of the present invention, several improvements and modifications may be made to the present invention, and these improvements and modifications also fall within the scope of protection of the claims of the present invention.
[0028] Therefore, the present invention will not be limited to these embodiments shown in this article, but can be applied to a wider range consistent with the principles and novel features disclosed herein. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art to which the present invention belongs.
[0029] As used in the specification and claims, the singular forms "a", "an", and "the" include plural referents unless the context clearly dictates otherwise.
[0030] All numerical values or expressions used in the specification and claims relating to component amounts, process conditions, etc. should be understood to be modified by "about" in all cases. The term "about" when referring to an amount or a numerical range means that the indicated amount or numerical range is an approximate value within the experimental variability (or within the statistical experimental error). In the present invention, the term "about" should have the meaning of within 10%, preferably within 5% of the specified value or range.
[0031] All ranges involving the same component or property include endpoints, which can be independently combined. Since these ranges are continuous, they include every numerical value between the minimum and maximum values. It should also be understood that any numerical range cited in the present invention is intended to include all subranges within the range.
[0032] The term "treatment" refers to reversing, alleviating, delaying the onset of, or inhibiting the progression of a disease described herein. In some embodiments, treatment may be administered after the disease has appeared or one or more signs or symptoms have been observed. In other embodiments, treatment may be administered in the absence of signs or symptoms of the disease. For example, treatment may be administered to susceptible subjects (e.g., based on a history of symptoms and / or based on exposure to pathogens) before the onset of symptoms to delay or prevent the occurrence of the disease. Treatment may also continue after symptoms disappear, for example, to delay and / or prevent recurrence.
[0033] The terms "disease" and "disorder" are used interchangeably.
[0034] An "effective amount" of a composition described herein refers to an amount sufficient to elicit a desired biological response. The effective amount of a composition described herein may vary depending on the following factors: the expected biological endpoint, the pharmacokinetics of the compound, the condition being treated, the mode of administration, and the age and health of the subject. In some embodiments, the effective amount is a therapeutically effective amount. In some embodiments, the effective amount is a prophylactically effective amount. In some embodiments, the effective amount is the amount of the composition described herein in a single dose. In some embodiments, the effective amount is the combined amount of the composition described herein in multiple doses.
[0035] A "therapeutically effective amount" of a composition described herein is an amount sufficient to provide a therapeutic benefit in treating a condition or to delay or minimize one or more symptoms associated with the condition. A therapeutically effective amount of a composition refers to an amount of a therapeutic agent that, alone or in combination with other therapies, provides a therapeutic benefit in treating the condition. The term "therapeutically effective amount" may include an amount that improves overall treatment, alleviates or eliminates symptoms, signs, or causes of the condition, and / or enhances the efficacy of another therapeutic agent.
[0036] The term "pharmaceutically acceptable" indicates that the composition is compatible with the other ingredients making up the formulation and / or the subject to be treated therewith.
[0037] The present invention does not limit the sources of the raw materials used. Unless otherwise specified, the raw materials used in the present invention are common commercial products in the technical field.
[0038] [Preparation of Chinese medicine composition]
[0039] Prescription: 50g ginseng, 2g deer antler, 20g astragalus, 20g tortoise shell glue, 20g rehmannia root, 20g Achyranthes bidentata, 20g yam, 30g salvia miltiorrhiza, 20g wolfberry, 20g dodder seed, 6g schisandra chinensis and 20g mistletoe.
[0040] Preparation method: for the above twelve herbs, take ginseng and heat and reflux extract with 60v / v% ethanol for three times, the first time for 3 hours, the second and third times for 2 hours each, and combine the extracts; recover the ethanol and concentrate to twice the original amount of the original medicine, add ethanol to 80wt% alcohol content, let it settle, take the supernatant, recover the ethanol, and concentrate to a relative density of 1.12-1.15 (50°C); add 50v / v% ethanol to heat and reflux extract four times, the first time for 3 hours, the second and third times for 2 hours each, the fourth time for 1 hour, combine the extracts, add water to the residue and boil it for three to five times, combine the decoction and the ethanol extract, filter, recover the ethanol from the filtrate and concentrate it to a ratio of the original amount of the original medicine The ratio of the raw materials is 1:1, ethanol is added to 85wt% alcohol, precipitation is allowed, the supernatant is taken, ethanol is recovered, and the relative density is concentrated to 1.12-1.15 (50°C); tortoise shell glue is heated and melted with water; the remaining nine herbs such as Astragalus are decocted with water three times, the first time for 3 hours, the second and third times for 2 hours each, the decoction is combined, filtered, and the filtrate is concentrated to 2 times the amount of the original medicinal material, ethanol is added to 65wt% alcohol, precipitation is allowed, the supernatant is recovered and ethanol is concentrated to a relative density of 1.12-1.15 (50°C); 650g of sucrose is dissolved in water, heated and boiled for 30 minutes to make a monosaccharide syrup; 1.5g of sorbic acid is dissolved in 140ml of ethanol. The above-mentioned medicinal liquids, monosaccharide syrup, and sorbic acid ethanol solution are combined, water is added to adjust to 1000ml, stirred evenly, allowed to stand, filtered, potted, and sterilized to obtain the product.
[0041] The Chinese medicine composition of the present invention can also be replaced by the commercially available Guiqishen oral liquid.
[0042] The efficacy of the Chinese medicine composition provided by the present invention in treating male reproductive diseases is examined below in conjunction with specific examples.
[0043] 1. Experimental Materials
[0044] 1.1 Experimental animals
[0045] Healthy SPF-grade SD rats, weighing 130-150 g, male, were purchased from Guangdong Medical Experimental Animal Center.
[0046] 1.2 Drugs and reagents
[0047] Hydrocortisone (Wuhan Weissman Bioengineering Co., Ltd., CAS: 50-23-7), isoflurane (Batch No.: 2023071501, Shenzhen Ruiwode Life Science Co., Ltd.), Jinkuishenqi Pills (commercially available), Chinese medicine composition (prepared in the embodiment of the present invention), rat testosterone (T) ELISA kit, rat superoxide dismutase (SOD) kit, and rat (MDA) ELISA kit were all purchased from Shanghai ELISA Biotechnology Co., Ltd.
[0048] 2. Modeling and grouping
[0049] Male SD rats were adaptively fed for 3-5 days, and 8 rats were selected as the normal control group. The rest were used as the model group. The rats were intramuscularly injected with 27 mg / kg hydrocortisone every day, and the normal control group was injected with an equal volume of normal saline for 21 consecutive days.
[0050] The model group was randomly divided into 3 groups, namely, the drug administration group, the positive drug group and the model control group, with 10 mice in each group. Among them, the drug administration group was gavaged with the Chinese medicine composition every day, with a dosage of 2mL / kg, the positive drug group was gavaged with Jinkui Shenqi Pills, with a dosage of 1.25g / kg, and the model control group and the normal control group were gavaged with an equal volume of normal saline. The drugs were administered at a fixed time every day, and each group was administered for 4 consecutive weeks.
[0051] 3. Sample collection
[0052] Rats were fasted but not watered 24 h before the last administration; 1 h after the last administration, SD rats were anesthetized by inhaled isoflurane and samples were collected. Blood was collected from the abdominal aorta, and the blood in the procoagulant blood collection tube was centrifuged at 4500 rpm for 5 min at 4°C. The upper serum was separated and stored in a −80°C refrigerator. Epididymal tissue was quickly removed and relevant indicators were examined.
[0053] 4. Serum biochemical test
[0054] According to the kit instructions, the levels of T, FSH, SOD and MDA in rat serum were detected.
[0055] 5. Sperm density and motility test
[0056] Take one side of the epididymis, cut it into pieces, put it into 1mL of physiological saline at 37℃, shake it for 15min, take 1 drop of the liquid and put it into a blood cell counting plate, count it under a microscope, and get the number of sperm contained in each milliliter of diluent. Take another drop of the liquid and put it into a blood cell counting plate, observe 200 sperm under a microscope, record the number of active sperm, and calculate the sperm motility rate according to the following formula.
[0057] Sperm motility rate = (a+b)*100 / 200; among them, grade a means that the sperm has excellent motility and moves forward in a fast straight line; grade b means that the sperm has good motility and moves forward in a straight line.
[0058] 6. Results
[0059] 6.1 Sperm density and sperm motility
[0060] Usually, sperm motility can be divided into 4 levels: A level indicates that the sperm has excellent motility and moves forward in a fast straight line; B level indicates that the sperm has good motility and moves forward in a straight line; C level indicates that the sperm has average motility and moves forward in a curve; D level indicates that the sperm has poor motility and only moves in place. The motility function or motility of sperm is directly related to human reproduction. Only sperm that moves forward normally can ensure that the sperm reaches the ampulla of the fallopian tube and combines with the egg to form a fertilized egg.
[0061] The results are shown in Table 1 below.
[0062] Table 1 Sperm count and sperm motility in rats
[0063]
[0064] Note: Different letters in the table indicate significant differences among the groups (P < 0.05).
[0065] The results showed that compared with the normal control group, the sperm motility of the rats in the model group was significantly reduced (P < 0.05), while there was no significant difference in sperm density (P > 0.05), indicating that hydrocortisone modeling can lead to reduced sperm motility in rats.
[0066] After 4 weeks of drug treatment, compared with the model group, the sperm motility of rats in the positive drug and administration groups was significantly increased (P < 0.05), indicating that both the positive drug and the Chinese medicine composition provided by the present invention can improve sperm motility.
[0067] Compared with the positive drug group, the sperm motility of the rats in the drug administration group was significantly increased (P < 0.05), and there was no significant difference compared with the rats in the normal control group (P > 0.05), indicating that the Chinese medicine composition of the present invention has a better effect of improving sperm motility than the positive drug.
[0068] 6.2 T and FSH levels in rat serum
[0069] Testosterone T is the main male hormone in the human body. It can promote the development of Wolffian ducts into epididymis, vas deferens and seminal vesicles, promote the growth and development of external reproductive organs and secondary sexual characteristics, and affect sperm production. FSH is follicle stimulating hormone, a glycoprotein hormone secreted by the gonadotropin cells of the pituitary gland, which can promote the maturation of the seminiferous tubules of the testicles and the production of sperm.
[0070] The levels of T and FSH in rat serum were detected, and the results are shown in Table 2.
[0071] Table 2 T and FSH levels in mouse serum
[0072]
[0073] Note: Different letters in the table indicate significant differences among the groups (P < 0.05).
[0074] The results showed that compared with the normal control group, the levels of T and FSH in the serum of rats in the model group were significantly decreased (P < 0.05), indicating that modeling would reduce the levels of T and FSH in the serum of rats.
[0075] After 4 weeks of drug treatment, the hormone levels in the serum of rats in the positive drug and drug administration groups were significantly increased compared with the model group (P < 0.05), and there was no significant difference in the values between the positive drug and drug administration groups.
[0076] It shows that the Chinese medicinal composition of the present invention has the effect of increasing hormones (T and FSH) in rat serum.
[0077] 6.3 SOD and MDA levels in rat serum
[0078] Superoxide dismutase (SOD), an oxidative and antioxidant system, exists in seminal plasma. It is an important oxygen free radical scavenger and plays a role in maintaining the normal morphology and function of sperm. The correlation between oxidative stress product malondialdehyde (MDA) and fertility and sperm parameters shows that the MDA level in the semen of infertile patients is significantly higher than that of normal fertile men, and is negatively correlated with sperm motility and density. Therefore, MDA can be used as a sensitive indicator for the diagnosis and treatment of infertility.
[0079] The levels of SOD and MDA in rat serum were detected, and the results are shown in Table 3.
[0080] Table 3 SOD and MDA levels in rat serum
[0081]
[0082] Note: Different letters in the table indicate significant differences among the groups (P < 0.05).
[0083] The results showed that compared with the normal control group, the SOD level in the serum of the rats in the model group was significantly decreased (P<0.05), and the MDA level was significantly increased (P<0.05).
[0084] After 4 weeks of drug treatment, compared with the model group, the SOD level in the serum of rats in the positive drug and administration groups was significantly increased (P < 0.05), and the MDA level was significantly decreased (P < 0.05).
[0085] At the same time, compared with the positive drug group, the MDA level in the serum of the rats in the drug administration group was significantly reduced (P < 0.05), indicating that the Chinese medicine composition of the present invention has a better effect of reducing the MDA level in serum than the positive drug.
[0086] The above is a further description of the present invention in conjunction with specific embodiments, but these embodiments are merely exemplary and do not constitute any limitation on the scope of the present invention. It should be understood by those skilled in the art that the details and forms of the technical solution of the present invention may be modified or replaced without departing from the spirit and scope of the present invention, but these modifications and replacements all fall within the scope of protection of the present invention.
Claims
1. An application of a traditional Chinese medicine composition in the preparation of a drug for treating oligospermia and asthenospermia, the traditional Chinese medicine composition being prepared from the following raw materials in parts by weight: 30-60 parts of ginseng, 0.5-4 parts of pilose antler, 15-35 parts of astragalus, 10-30 parts of tortoise shell glue, 15-35 parts of prepared rehmannia, 10-30 parts of achyranthes, 15-40 parts of yam, 20-40 parts of salvia miltiorrhiza, 15-30 parts of wolfberry, 15-30 parts of dodder seed, 2-8 parts of schisandra chinensis and 10-30 parts of mistletoe.
2. The use according to claim 1, It is characterized in that The medicine is in the form of oral liquid, tablet, pill, capsule, granule, powder, injection or suspension.
3. The use according to claim 2, It is characterized in that The medicine is in the form of oral liquid, tablet, capsule, granule or powder.
4. The use according to any one of claims 1 to 3, It is characterized in that The medicament includes a pharmaceutically acceptable carrier.
